|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/20/18 Emmaus Life Sciences, Inc. 10-Q 12/31/17 59:4.9M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 386K
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 23K
3: EX-10.32 Material Contract HTML 90K
4: EX-10.33 Material Contract HTML 90K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
14: R1 Document and Entity Information HTML 44K
15: R2 Unaudited Condensed Consolidated Balance Sheets HTML 111K
16: R3 Unaudited Condensed Consolidated Balance Sheets HTML 40K
(Parenthetical)
17: R4 Unaudited Condensed Consolidated Statements of HTML 57K
Operations
18: R5 Unaudited Condensed Consolidated Statements of HTML 88K
Cash Flows
19: R6 Organization and Nature of Operations HTML 42K
20: R7 Summary of Significant Accounting Policies HTML 90K
21: R8 Accounts Receivable HTML 24K
22: R9 Long - Term Borrowings and Other Note Payables HTML 23K
23: R10 Acquisition HTML 47K
24: R11 Stockholders' Equity HTML 152K
25: R12 Income Taxes HTML 26K
26: R13 Related Party Transactions HTML 29K
27: R14 Loss Per Share HTML 33K
28: R15 Commitments and Contingent Liabilities HTML 32K
29: R16 Summary of Significant Accounting Policies HTML 151K
(Policies)
30: R17 Summary of Significant Accounting Policies HTML 39K
(Tables)
31: R18 Accounts Receivable (Tables) HTML 23K
32: R19 Acquisition (Tables) HTML 43K
33: R20 Stockholders' Equity (Tables) HTML 102K
34: R21 Loss Per Share (Tables) HTML 32K
35: R22 Organization and Nature of Operations (Details HTML 109K
Narrative)
36: R23 Summary of Significant Accounting Policies HTML 21K
(Details)
37: R24 Summary of Significant Accounting Policies HTML 24K
(Details 1)
38: R25 Summary of Significant Accounting Policies HTML 31K
(Details 2)
39: R26 Summary of Significant Accounting Policies HTML 67K
(Details Narrative)
40: R27 Accounts Receivable (Details) HTML 25K
41: R28 Long - Term Borrowings and Other Note Payables HTML 42K
(Details Narrative)
42: R29 Acquisition (Details) HTML 64K
43: R30 Acquisition (Details 1) HTML 27K
44: R31 Acquisition (Details Narrative) HTML 53K
45: R32 Stockholders' Equity (Details) HTML 29K
46: R33 Stockholders' Equity (Details 1) HTML 24K
47: R34 Stockholders' Equity (Details 2) HTML 51K
48: R35 Stockholders' Equity (Details 3) HTML 37K
49: R36 Stockholders' Equity (Details 4) HTML 30K
50: R37 Stockholders' Equity (Details 5) HTML 52K
51: R38 Stockholders' Equity (Details Narrative) HTML 525K
52: R39 Stockholders' Equity (Details Narrative 1) HTML 27K
53: R40 Income Taxes (Details Narrative) HTML 33K
54: R41 Related Party Transactions (Details Narrative) HTML 63K
55: R42 Loss Per Share (Details) HTML 37K
56: R43 Commitments and Contingent Liabilities (Details HTML 75K
Narrative)
58: XML IDEA XML File -- Filing Summary XML 98K
57: EXCEL IDEA Workbook of Financial Reports XLSX 81K
8: EX-101.INS XBRL Instance -- mynd-20171231 XML 1.33M
10: EX-101.CAL XBRL Calculations -- mynd-20171231_cal XML 145K
11: EX-101.DEF XBRL Definitions -- mynd-20171231_def XML 600K
12: EX-101.LAB XBRL Labels -- mynd-20171231_lab XML 984K
13: EX-101.PRE XBRL Presentations -- mynd-20171231_pre XML 783K
9: EX-101.SCH XBRL Schema -- mynd-20171231 XSD 140K
59: ZIP XBRL Zipped Folder -- 0001615774-18-001326-xbrl Zip 143K
Exhibit 3.1
CERTIFICATE OF AMENDMENT OF
CERTIFICATE OF INCORPORATION OF
MYND ANALYTICS, INC.
MYnd Analytics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:
FIRST: That the Board of Directors (the “Board”) of MYnd Analytics, Inc. (the “Corporation”) on March 22, 2017, duly adopted resolutions ("Resolutions") setting forth a proposed amendment of the Certificate of Incorporation of the Corporation approving of a reduction in the number of authorized shares of Common Stock which the Corporation is authorized to issue from 500,000,000 to 250,000,000 (the “Share Reduction”), (hereinafter the “Amendment”), and declaring such Amendment effecting the Share Reduction to be advisable and calling for consideration and approval of the Amendment by stockholders of the Corporation.
SECOND: In accordance with the Resolutions, this Certificate of Amendment (the "Certificate of Amendment") amends the provisions of the Corporation's Certificate of Incorporation, as amended, filed with the Secretary of State of the State of Delaware (the "Certificate of Incorporation").
THIRD: That Article IV of the Certificate of Incorporation of the Corporation is hereby amended and restated in its entirety, as follows:
ARTICLE IV
CAPITAL STOCK
Section 4.A. The total number of shares of stock which the Corporation shall have authority to issue is Two Hundred Sixty Five Million (265,000,000).
Section 4.B. Common Stock. The total number of shares of Common Stock which the Corporation shall have authority to issue is Two Hundred and Fifty Million (250,000,000), with a par value of $0.001 per share. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Corporation’s Common Stock.
Section 4.C. Blank-Check Preferred Stock. The total number of shares of undesignated preferred stock which the Corporation shall have the authority to issue is Fifteen Million (15,000,000) shares, with a par value of $0.001 per share. The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
FOURTH: That pursuant to the Resolutions, an annual meeting of the stockholders of the Corporation was duly called and held on August 21, 2017 upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.
FIFTH: That said Amendment was duly adopted on August 21, 2017 in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
SIXTH: All other provisions of the Certificate of Incorporation shall remain in full force and effect.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of MYnd Analytics, Inc. as of December 29, 2017.
| MYND ANALYTICS, INC. | ||
| By: | /s/ George C. Carpenter IV | |
| Name: | George C. Carpenter IV | |
| Title: | President & Chief Executive Officer | |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/20/18 | 8-K/A | ||
| For Period end: | 12/31/17 | NT 10-Q | ||
| 12/29/17 | 10-K | |||
| 8/21/17 | 4, 8-K | |||
| 3/22/17 | 4 | |||
| List all Filings | ||||